Skip to main content

Canada Dry Eyes Treatment: Lubricating Drops With Sodium Hyaluronate Announced

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

mEYEspa has announced the availability of HYLO dry eye drops, a preservative-free sodium hyaluronate line formulated with high molecular weight technology to support longer ocular surface retention and sustained dry eye relief.

-- mEYEspa has introduced its HYLO lubricating dry eye drops for Canadian patients, offering long-lasting relief from dry eye symptoms. The product line is formulated with sodium hyaluronate to support prolonged moisture retention and improved tear film stability.

More information is available at https://www.meyespa.com/blogs/eye-care-news/how-hylo-can-benefit-your-dry-eye

According to the Waterloo Eye Institute, up to 30% of Canadians suffer from dry eye disease, with the number expected to rise due to increased screen use and demographic aging. mEYEspa has presented its HYLO dry eye drops to address this by offering Canadian patients access to a clinically grounded sodium hyaluronate formulation

"What separates HYLO from conventional over-the-counter alternatives is the quality and structure of its active ingredient," says London, Ontario Optometrist Dr Jason Morris. "While many dry eye drops list hyaluronic acid on their label, the type - i.e., molecular weight - of that ingredient varies considerably between products, and that variation has a measurable impact on how long the drop remains effective on the eye."

HYLO uses a natural, high-molecular-weight form of sodium hyaluronate that is shown to bind more effectively to the tear film, staying on the ocular surface longer and reducing the need for frequent reapplication throughout the day.

According to the company spokesperson, the product range is also preservative-free, delivered through a multidose bottle system that remains safe to use for six months after opening. This makes it a practical option for patients managing dry eye on an ongoing basis, particularly those who have experienced irritation from preservatives found in standard drops.

The HYLO range includes four formulations: HYLO (0.1% sodium hyaluronate), HYLO GEL (0.2% sodium hyaluronate), HYLO DUAL, and HYLO DUAL Intense. The team highlights that this range allows patients and clinicians to select an option suited to the severity and nature of their symptoms.

The product blurs minimally on instillation, feels comfortable on the eye, and provides immediate and sustained comfort for dry eye sufferers.

Individuals interested in learning more about the product or ordering it may visit https://www.meyespa.com/blogs/eye-care-news/how-hylo-can-benefit-your-dry-eye

Contact Info:
Name: Dr. Jason Morris
Email: Send Email
Organization: mEYEspa
Address: 102-1750 Ernest Ave, London, ON N6E 3H3, Canada
Website: https://www.mEYEspa.com

Source: PressCable

Release ID: 89192634

If there are any problems, discrepancies, or queries related to the content presented in this press release, we kindly ask that you notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or support you with press release takedowns. Ensuring accurate and trustworthy information is our unwavering commitment.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  266.32
-2.14 (-0.80%)
AAPL  308.82
+3.83 (1.26%)
AMD  467.51
+17.92 (3.99%)
BAC  51.80
+0.31 (0.60%)
GOOG  379.38
-4.09 (-1.07%)
META  610.26
+2.88 (0.47%)
MSFT  418.57
-0.52 (-0.12%)
NVDA  215.33
-4.18 (-1.90%)
ORCL  192.08
+2.31 (1.22%)
TSLA  426.01
+8.16 (1.95%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.